[go: up one dir, main page]

IL106237A0 - Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis - Google Patents

Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis

Info

Publication number
IL106237A0
IL106237A0 IL106237A IL10623793A IL106237A0 IL 106237 A0 IL106237 A0 IL 106237A0 IL 106237 A IL106237 A IL 106237A IL 10623793 A IL10623793 A IL 10623793A IL 106237 A0 IL106237 A0 IL 106237A0
Authority
IL
Israel
Prior art keywords
inhibitors
sulfoxamides
sulfonamides
cholesterol biosynthesis
piperidyl
Prior art date
Application number
IL106237A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL106237A0 publication Critical patent/IL106237A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other Liquid Machine Or Engine Such As Wave Power Use (AREA)
IL106237A 1992-07-08 1993-07-05 Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis IL106237A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91060492A 1992-07-08 1992-07-08

Publications (1)

Publication Number Publication Date
IL106237A0 true IL106237A0 (en) 1993-11-15

Family

ID=25429048

Family Applications (1)

Application Number Title Priority Date Filing Date
IL106237A IL106237A0 (en) 1992-07-08 1993-07-05 Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis

Country Status (14)

Country Link
US (2) US5350758A (xx)
EP (1) EP0650474B1 (xx)
JP (1) JPH07508732A (xx)
KR (1) KR100286410B1 (xx)
AT (1) ATE169618T1 (xx)
AU (1) AU678973B2 (xx)
CA (1) CA2136841C (xx)
DE (1) DE69320352T2 (xx)
ES (1) ES2120506T3 (xx)
IL (1) IL106237A0 (xx)
MX (1) MX9304070A (xx)
NZ (1) NZ253592A (xx)
WO (1) WO1994001404A1 (xx)
ZA (1) ZA934777B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103733A (en) * 1998-09-09 2000-08-15 Bachmann; Kenneth A. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes
KR100601501B1 (ko) * 2004-09-24 2006-07-18 삼성에스디아이 주식회사 이차전지의 팩 케이스
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
EP2571860A1 (en) 2010-05-21 2013-03-27 Pfizer Inc 2-phenyl benzoylamides
US20130345392A1 (en) 2011-03-04 2013-12-26 Pfizer Inc Edn3-like peptides and uses thereof
CA2909442A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
HUE069590T2 (hu) 2019-01-18 2025-03-28 Astrazeneca Ab PCSK9-gátló 6'-[[(1s,3s)-3-[[5-(difluormetoxi)-2-pirimidinil]amino]ciklopentil]amino][1(2h ),3'-bipiridin]-2-on és alkalmazására szolgáló eljárások

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2580411A (en) * 1948-10-23 1952-01-01 Searle & Co Dihexyl alanine dialkylamides
FR1261160A (fr) * 1955-07-28 1961-05-19 Procédé de préparation de n-t-alkyl-dialkylamino-amides
NL109859C (xx) * 1957-09-27
US3185678A (en) * 1961-08-04 1965-05-25 Colgate Palmolive Co Polymethyleniminoalkylamides
US3178439A (en) * 1963-05-06 1965-04-13 Reilly Tar & Chem Corp N-alkanoyl and alkenoyl hydroxy alkyl piperidides
CH448086A (de) * 1965-01-15 1967-12-15 Geigy Ag J R Verfahren zur Herstellung von neuen Derivaten des 1,2,3,6-Tetrahydro-pyridins
DE1719388B2 (de) * 1968-02-09 1976-04-29 Bayer Ag, 5090 Leverkusen Verfahren zum faerben von fasermaterialien aus polyacrylnitril oder acrylnitrilhaltigen mischpolymerisaten
GB1415682A (en) * 1972-06-30 1975-11-26 Wyeth John & Brother Ltd Amides and thioamides
GB1420758A (en) * 1972-07-12 1976-01-14 Wyeth John & Brother Ltd Anti-ulcer compositions
US3968211A (en) * 1974-02-11 1976-07-06 The Upjohn Company Compositions and methods of use of amidines for anti-arrhythmic purposes
JPS5344573A (en) * 1976-10-01 1978-04-21 Teijin Ltd Optical active 2-piperidineethanols and their preparation
US4316903A (en) * 1977-07-18 1982-02-23 Merck & Co., Inc. Anti-microbial piperidino buten-2-ones
JPS55129255A (en) * 1979-03-28 1980-10-06 Kuraray Co Ltd Farnesylacetamide compounds or their salts
DE2947649A1 (de) * 1979-11-27 1981-08-06 C.F. Spiess & Sohn GmbH & Co, 6719 Kleinkarlbach Insektizide mittel
US4565819A (en) * 1979-12-07 1986-01-21 Adir Substituted imino diacids, their preparation and pharmaceutical compositions which contain them
US4326067A (en) * 1980-12-03 1982-04-20 The Dow Chemical Company Process for making N-(2-aminoethyl)amides
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
DE3433036A1 (de) * 1984-09-08 1986-03-20 Basf Ag, 6700 Ludwigshafen Piperidinderivate und diese enthaltende fungizide sowie verfahren zur bekaempfung von pilzen
US4812451A (en) * 1984-10-19 1989-03-14 A. H. Robins Company, Incorporated 1-(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-α,.alpha.
US4906659A (en) * 1985-06-18 1990-03-06 Takeda Chemical Industries, Ltd. Antibiotic tan-749, its derivatives, production and use thereof
ES2053527T3 (es) * 1986-02-01 1994-08-01 Nippon Chemiphar Co Derivados de alquilendiamina.
DE3814549A1 (de) * 1987-10-30 1989-05-18 Bayer Ag N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln
DK168069B1 (da) * 1987-11-11 1994-01-31 Hoffmann La Roche Isoquinolinderivater og en fremgangsmaade til fremstilling af octahydroisoquinoliner ud fra derivaterne
FR2649490B1 (fr) * 1989-07-07 1991-09-20 Thomson Csf Capteur de rayonnement d'energie electromagnetique
CA2025490C (en) * 1989-09-22 2003-09-16 James R. Mccarthy Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis
EP0421441B1 (en) * 1989-10-06 1995-01-25 Fujirebio Inc. Pantothenic acid derivatives
AU638852B2 (en) * 1990-07-24 1993-07-08 Merrell Dow Pharmaceuticals Inc. Novel substituted piperidines and their use as inhibitors of cholesterol synthesis
CA2047375C (en) * 1990-07-25 2003-04-15 Charlotte L. Barney Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
DK0471236T3 (da) * 1990-07-30 1995-07-24 Takeda Chemical Industries Ltd Imidazopyridinderivater og deres anvendelse
US5084461A (en) * 1991-03-27 1992-01-28 Merrell Dow Pharmaceuticals Inc. Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis

Also Published As

Publication number Publication date
KR100286410B1 (ko) 2001-04-16
AU4403793A (en) 1994-01-31
AU678973B2 (en) 1997-06-19
US5489600A (en) 1996-02-06
DE69320352T2 (de) 1998-12-17
KR950702534A (ko) 1995-07-29
MX9304070A (es) 1994-02-28
CA2136841C (en) 1998-10-06
ZA934777B (en) 1994-01-20
US5350758A (en) 1994-09-27
WO1994001404A1 (en) 1994-01-20
ATE169618T1 (de) 1998-08-15
ES2120506T3 (es) 1998-11-01
NZ253592A (en) 1996-04-26
DE69320352D1 (de) 1998-09-17
JPH07508732A (ja) 1995-09-28
EP0650474B1 (en) 1998-08-12
CA2136841A1 (en) 1994-01-20
EP0650474A1 (en) 1995-05-03

Similar Documents

Publication Publication Date Title
EP0687183A4 (en) SYNERGISTIC COMPOSITION CONSISTING OF A CD4-BASED PROTEIN AND ANTI-HIV-1 ANTIBODY, AND METHODS FOR THE USE THEREOF
YU53899A (sh) Primena inhibitora ciklooksigenaze-2 u prevenciji kardiovaskularnih poremećaja
BG102071A (en) Minor molecule inhibitors of rotamase enzymic activity
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
FI955315L (fi) HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon
AU8377698A (en) Inhibitors of p38
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
DK0783297T3 (da) Polyethylenglycol-modificerede ceramid-lipider og liposomer
MY132496A (en) Inhibitors of p38
MY117696A (en) INHIBITORS OF p38
TW225534B (xx)
ZA915659B (en) Novel piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis
IL126109A0 (en) Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
IL106237A0 (en) Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis
IL117209A (en) 1-aryl-2-acylamino-ethane compounds and pharmaceutical compositions containing them
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
BG103306A (en) Liquid allendronate compositions
BG104292A (en) Methods and compositions for the treatment of rheumatoid arthritis
DE3560313D1 (en) Improvements in or relating to anticonvulsant agents
DE3674971D1 (en) P-acylaminobenzamide.
BR9712332A (pt) Composições detergentes contendo isopeptidade
BG104839A (en) Chrystalline form of paroxetine
BG103305A (en) Intermediate compounds for the preparation of hiv protease inhibitors and methods for the preparation of hiv protease inhibitors